+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

European COVID-19 Diagnostics Market 2020-2026

  • ID: 5190216
  • Report
  • October 2020
  • Region: Europe
  • Orion Market Research Private Limited

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Altona Diagnostics GmbH
  • BforCure
  • BioMérieux S.A.
  • Edinburgh Genetics, Ltd.
  • ERBA Mannheim
  • F. Hoffmann-La Roche AG
  • MORE
European COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-Users (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026
European COVID-19 diagnostics market is estimated to see a decline in CAGR of 28.2% during the forecast period. European COVID-19 diagnostics market is witnessing optimal growth owing to the expansion of COVID-19 testing capacity in the region. The European government has made some plans to combat the COVID-19 pandemic, which includes improving infrastructure for diagnosis and treatment. So far, a large number of COVID-19 tests are available in the EU, and some new tests are being developed. RT-PCR testing is widely used for COVID-19 testing in the region, owing to potential availability, cost-effectiveness, and efficiency. Theoretically, RT-PCR tests provide better accuracy, however, some tests may offer false-negative results for mild cases. Moreover, the results might take some days to come back as samples require to be sent to the lab facilities. The increasing speed issue is key to strong innovation at present in the region. To overcome this challenge, European companies have taken some key steps to advance PCR testing.

European COVID-19 diagnostics market is segmented based on technology type, end-use, sample type, and product type. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others. European COVID-19 diagnostics market is segmented based on countries, the UK, Germany, France, Spain, Italy, and the Rest of Europe. UK held the largest market value in the European COVID-19 diagnostics market. The availability of the various advanced test for the COVID-19 coupled with the high number of cases in the country further contribute to the market share.

The companies which are contributing to the growth of the European COVID-19 diagnostics market include BioMérieux SA, F. Hoffmann-La Roche AG, Molecular Biology Systems, Altona Diagnostics GmbH, and Edinburgh Genetics Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in May 2020, Roche declared that the US FDA has issued a EUA for its new Elecsys Anti-SARS-CoV-2 antibody test. The test is designed to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV-2. Roche has already started shipping the new antibody test to leading laboratories globally and will ramp up production capacity to high double-digit millions per month to serve healthcare systems in countries accepting the CE mark as well as the US. The serology test has a specificity greater than 99.8% and a sensitivity of 100% (14 Days post-PCR confirmation).

Research Methodology

The market study of the European COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

1. European COVID-19 Diagnostics Market Research and Analysis by Type
2. European COVID-19 Diagnostics Market Research and Analysis by Technology Type
3. European COVID-19 Diagnostics Market Research and Analysis by Sample Type
4. European COVID-19 Diagnostics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the European COVID-19 diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the European COVID-19 diagnostics market.
  • Insights about market determinants which are stimulating the European COVID-19 diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Altona Diagnostics GmbH
  • BforCure
  • BioMérieux S.A.
  • Edinburgh Genetics, Ltd.
  • ERBA Mannheim
  • F. Hoffmann-La Roche AG
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. European COVID-19 Diagnostics Market by Type
5.1.1. Instruments
5.1.2. Reagents & Kits
5.1.3. Laboratory Testing Services
5.2. European COVID-19 Diagnostics Market by Technology Type
5.2.1. PCR Test
5.2.2. Antigen Test
5.2.2.1. Chromatographic Immunoassay
5.2.2.2. Fluorescent Immunoassay
5.2.2.3. Chemiluminescent Immunoassay
5.2.3. Serology Test
5.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3.2. Neutralization
5.2.3.3. Chemiluminescent Immunoassay
5.2.4. Rapid/ PoC Test
5.3. European COVID-19 Diagnostics Market by Sample Type
5.3.1. Oropharyngeal & Nasopharyngeal Swabs
5.3.2. Blood
5.3.3. Urine
5.3.4. Saliva
5.3.5. Others (Sperm)
5.4. European COVID-19 Diagnostics Market by End-Users
5.4.1. Laboratories
5.4.2. Hospitals
5.4.3. Diagnostic Centers & Clinics
5.4.4. Research Institutes

6. Regional Analysis
6.1. UK
6.2. Germany
6.3. Spain
6.4. France
6.5. Italy
6.6. Rest of Europe

7. Company Profiles
7.1. Altona Diagnostics GmbH
7.2. BforCure
7.3. BioMérieux S.A.
7.4. Edinburgh Genetics, Ltd.
7.5. ERBA Mannheim
7.6. F. Hoffmann-La Roche AG
7.7. Molecular Biology Systems
7.8. Mologic, Ltd.
7.9. NOWDiagnostics, Inc.
7.10. Surescreen Diagnostics Ltd.

List of Tables

List of Figures
Note: Product cover images may vary from those shown
  • Altona Diagnostics GmbH
  • BforCure
  • BioMérieux S.A.
  • Edinburgh Genetics, Ltd.
  • ERBA Mannheim
  • F. Hoffmann-La Roche AG
  • Molecular Biology Systems
  • Mologic, Ltd.
  • NOWDiagnostics, Inc.
  • Surescreen Diagnostics Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll